Chambers and Partners has recently published its 2024 Life Sciences Global Practice Guide. Markwell Clarizio LLP is very pleased to have been invited to be the exclusive author of the Canadian sections of this comprehensive practice guide which is considered the “definitive global law guide offering comparative analysis from top ranked lawyers”.
In the Canadian chapter of the Chambers Life Sciences Global Practice Guide, Jason Markwell, Dino Clarizio, Rebecca Crane and David Park provide the latest information on the marketing, manufacturing, and distribution of pharmaceuticals and medical devices, pricing, digital health care, clinical trials, patents, and developments related to COVID-19 in Canada.
In the Canadian Trends and Development section, the same contributors discuss several notable trends and developments in Canadian life sciences law, including the national life sciences strategy, pharmacare, dental care programme, rare diseases, patented drug pricing reform, bulk export of drugs to the United States, and biosimilars.
The 2024 Life Sciences Global Practice Guide can be found at the link below:
Life Sciences 2024 – Canada | Global Practice Guides | Chambers and Partners